Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Journal of Gastroenterology and Hepatology
|
May 15, 2025
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study
Tadakazu Hisamatsu, Taku Kobayashi, Satoshi Motoya, et al.
Intestinal Research
|
January 16, 2025
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study
Taku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Gastro Hep Advances
|
November 24, 2025
Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study
Hiroshi Nakase, Toshimitsu Fujii, Tadakazu Hisamatsu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 28, 2026
Long-term Safety of Upadacitinib in Patients with Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies
Remo Panaccione, Julián Panés, Laurent Peyrin-Biroulet, et al.
Inflammatory Intestinal Diseases
|
July 16, 2025
Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis Patients over and under 65 Years of Age: A Real-World Comparative Analysis
Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura, et al.
Inflammatory Intestinal Diseases
|
May 22, 2019
Risk Factors for Mortality in <i>Pneumocystis jirovecii</i> Pneumonia in Patients with Inflammatory Bowel Disease
Atsushi Yoshida, Noriko Kamata, Akihiro Yamada, et al.
Alimentary Pharmacology & Therapeutics
|
November 23, 2024
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan
Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura, et al.
BMJ Open Gastroenterology
|
November 14, 2023
COVID-19 severity is associated with the risk of gastrointestinal bleeding
Shuji Hibiya, Takashi Fujii, Toshimitsu Fujii, et al.
Alimentary Pharmacology & Therapeutics
|
March 18, 2024
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan
Shintaro Akiyama, Kaoru Yokoyama, Soichi Yagi, et al.
Journal of Gastroenterology and Hepatology
|
May 3, 2019
Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine
Shintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Journal of Gastroenterology and Hepatology
|
May 15, 2025
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study
Tadakazu Hisamatsu, Taku Kobayashi, Satoshi Motoya, et al.
Intestinal Research
|
January 16, 2025
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study
Taku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Gastro Hep Advances
|
November 24, 2025
Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study
Hiroshi Nakase, Toshimitsu Fujii, Tadakazu Hisamatsu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 28, 2026
Long-term Safety of Upadacitinib in Patients with Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies
Remo Panaccione, Julián Panés, Laurent Peyrin-Biroulet, et al.
Inflammatory Intestinal Diseases
|
July 16, 2025
Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis Patients over and under 65 Years of Age: A Real-World Comparative Analysis
Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura, et al.
Inflammatory Intestinal Diseases
|
May 22, 2019
Risk Factors for Mortality in <i>Pneumocystis jirovecii</i> Pneumonia in Patients with Inflammatory Bowel Disease
Atsushi Yoshida, Noriko Kamata, Akihiro Yamada, et al.
Alimentary Pharmacology & Therapeutics
|
November 23, 2024
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan
Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura, et al.
BMJ Open Gastroenterology
|
November 14, 2023
COVID-19 severity is associated with the risk of gastrointestinal bleeding
Shuji Hibiya, Takashi Fujii, Toshimitsu Fujii, et al.
Alimentary Pharmacology & Therapeutics
|
March 18, 2024
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan
Shintaro Akiyama, Kaoru Yokoyama, Soichi Yagi, et al.
Journal of Gastroenterology and Hepatology
|
May 3, 2019
Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine
Shintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, et al.
Page
of 9